The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000–2009: The Way Forward
2011

The WHO's Efforts to Control Human African Trypanosomiasis (Sleeping Sickness) from 2000 to 2009

publication Evidence: high

Author Information

Author(s): Simarro Pere P., Diarra Abdoulaye, Ruiz Postigo Jose A., Franco José R., Jannin Jean G.

Primary Institution: World Health Organization

Conclusion

The number of new cases of human African trypanosomiasis reported to WHO has dropped below 10,000 for the first time in 50 years, indicating significant progress in control efforts.

Supporting Evidence

  • WHO's support led to a significant reduction in the use of melarsoprol for treating second stage gambiense cases.
  • Training programs were implemented to improve the capacity of health staff in endemic countries.
  • WHO's initiatives resulted in a 63% decrease in reported cases since 2000.

Takeaway

The WHO and its partners have worked hard to reduce the number of people getting sick from sleeping sickness, and now fewer than 10,000 new cases are reported each year.

Methodology

The WHO provided technical assistance, access to diagnosis and treatment, and training to health staff in endemic countries.

Potential Biases

Potential bias due to reliance on reported cases, which may underestimate the true number of infections.

Limitations

The decline in support from NGOs and bilateral cooperation poses a risk to the sustainability of control efforts.

Participant Demographics

Countries listed as endemic for human African trypanosomiasis, including Benin, Burkina Faso, Cameroon, and others.

Digital Object Identifier (DOI)

10.1371/journal.pntd.0001007

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication